Last 12 months
Inside the activity.
0 purchase rows · 57 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 16 |
| Dec 2025 | 0 | 12 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 8 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 4 |
| Jun 2026 | 0 | 8 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 9 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 06, 2020 Filed Jul 7, 2020 21:47 UTC |
Kennedy KeithCOO / CFO
|
Exercise / conversionCommon Stock | 10,075 | $5.98 | $60,248.50 |
DisclosureSEC source: 0001437749-20-014799 · rdgdoc.xml · nonDerivative · entry 3 Kennedy Keith · CIK 0001543503 · COO / CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 162,726 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on May 11, 2020. Read SEC document |
| July 02, 2020 Filed Jul 7, 2020 21:47 UTC |
Kennedy KeithCOO / CFO
|
Exercise / conversionStock Option (right to buy) · Derivative | 2,800 | $0.00 Strike: $5.98 | $0.00 |
DisclosureSEC source: 0001437749-20-014799 · rdgdoc.xml · derivative · entry 7 Kennedy Keith · CIK 0001543503 · COO / CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,092 Underlying: Common Stock · 2,800 shares Expires 2028-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on May 11, 2020. F4 · derivative.exercise_date: The option becomes exercisable as to 25% of the shares on March 2, 2019, and the remaining shares vest at a rate of 1/48th of the total number of shares subject to the award for each month of continuous service thereafter. Read SEC document |
| July 02, 2020 Filed Jul 7, 2020 21:47 UTC |
Kennedy KeithCOO / CFO
|
SaleCommon Stock | 5,747 | $28.02 | $161,040.14 |
DisclosureSEC source: 0001437749-20-014799 · rdgdoc.xml · nonDerivative · entry 2 Kennedy Keith · CIK 0001543503 · COO / CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 152,651 F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on May 11, 2020. F2 · price: Represents weighted average sales price. Sale prices for the transactions range from $28.00 to $28.15. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request. Read SEC document |
| July 02, 2020 Filed Jul 7, 2020 21:47 UTC |
Kennedy KeithCOO / CFO
|
Exercise / conversionCommon Stock | 2,800 | $5.98 | $16,744.00 |
DisclosureSEC source: 0001437749-20-014799 · rdgdoc.xml · nonDerivative · entry 1 Kennedy Keith · CIK 0001543503 · COO / CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 158,398 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on May 11, 2020. Read SEC document |
| July 01, 2020 Filed Jul 2, 2020 20:40 UTC |
Kennedy KeithCOO / CFO
|
Tax withholdingCommon Stock | 2,106 | $26.73 | $56,293.38 |
DisclosureSEC source: 0001437749-20-014544 · rdgdoc.xml · nonDerivative · entry 1 Kennedy Keith · CIK 0001543503 · COO / CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 155,598 F1 · kind: The reporting person is reporting the withholding of 2,106 shares of common stock to satisfy the reporting person's tax withholding obligations in connection with the vesting of 4,000 Restricted Stock Units granted on July 1, 2019 and does not represent a sale by the reporting person. Read SEC document |
| June 10, 2020 Filed Jun 11, 2020 23:06 UTC |
Anderson Bonnie HDirector · Chairman and CEO
|
Exercise / conversionStock Option (right to buy) · Derivative | 20,000 | $0.00 Strike: $4.00 | $0.00 |
DisclosureSEC source: 0001384101-20-000099 · wf-form4_159191678078425.xml · derivative · entry 4 Anderson Bonnie H · CIK 0001588970 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,853 Underlying: Common Stock · 20,000 shares Expires 2023-02-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 2, 2019. F3 · shares: On February 5, 2013, the Reporting Person was issued 3 stock options which have different vesting dates, all of which are vested. These options include: (1) 112,500, of which 25,000 options remain, (2) 12,500, of which none remain and (3) 24,112, of which 20,000 were exercised on 6/10/2020 and 1,853 remain. F4 · derivative.exercise_date: The options are fully vested. Read SEC document |
| June 10, 2020 Filed Jun 11, 2020 23:06 UTC |
Anderson Bonnie HDirector · Chairman and CEO
|
SaleCommon Stock | 20,000 | $26.56 | $531,260.00 |
DisclosureSEC source: 0001384101-20-000099 · wf-form4_159191678078425.xml · nonDerivative · entry 2 Anderson Bonnie H · CIK 0001588970 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 272,207 F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 2, 2019. F2 · price: Represents weighted average sales price. Sale prices for the transactions range from $26.15 to $27.01. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request. Read SEC document |
| June 10, 2020 Filed Jun 11, 2020 23:06 UTC |
Anderson Bonnie HDirector · Chairman and CEO
|
Exercise / conversionCommon Stock | 20,000 | $4.00 | $80,000.00 |
DisclosureSEC source: 0001384101-20-000099 · wf-form4_159191678078425.xml · nonDerivative · entry 1 Anderson Bonnie H · CIK 0001588970 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 292,207 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 2, 2019. Read SEC document |
| June 08, 2020 Filed Jun 9, 2020 20:30 UTC |
JONES EVAN/ FADirector
|
GrantStock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $26.30 | $0.00 |
DisclosureSEC source: 0001384101-20-000087 · wf-form4_159173461625244.xml · derivative · entry 1 JONES EVAN/ FA · CIK 0001020741 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2030-06-07 F1 · derivative.exercise_date: The option becomes exercisable in full on June 8, 2021 or immediately prior to the Company's next annual meeting of stockholders, if earlier. In addition, the option vests in full in the event of a change in control of the Company. Read SEC document |
| June 08, 2020 Filed Jun 9, 2020 20:43 UTC |
Nova Tina SusanDirector
|
GrantStock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $26.30 | $0.00 |
DisclosureSEC source: 0001384101-20-000091 · wf-form4_159173536634967.xml · derivative · entry 1 Nova Tina Susan · CIK 0001302605 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2030-06-07 F1 · derivative.exercise_date: The option becomes exercisable in full on June 8, 2021 or immediately prior to the Company's next annual meeting of stockholders, if earlier. In addition, the option vests in full in the event of a change in control of the Company. Read SEC document |
| June 08, 2020 Filed Jun 9, 2020 20:33 UTC |
EPSTEIN ROBERT SDirector
|
GrantStock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $26.30 | $0.00 |
DisclosureSEC source: 0001384101-20-000089 · wf-form4_159173477205679.xml · derivative · entry 1 EPSTEIN ROBERT S · CIK 0001252004 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2030-06-07 F1 · derivative.exercise_date: The option becomes exercisable in full on June 8, 2021 or immediately prior to the Company's next annual meeting of stockholders, if earlier. In addition, the option vests in full in the event of a change in control of the Company. Read SEC document |
| June 08, 2020 Filed Jun 9, 2020 20:47 UTC |
EASTHAM KARINDirector
|
GrantStock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $26.30 | $0.00 |
DisclosureSEC source: 0001384101-20-000095 · wf-form4_159173563548456.xml · derivative · entry 1 EASTHAM KARIN · CIK 0001231845 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2030-06-07 F1 · derivative.exercise_date: The option becomes exercisable in full on June 8, 2021 or immediately prior to the Company's next annual meeting of stockholders, if earlier. In addition, the option vests in full in the event of a change in control of the Company. Read SEC document |
| June 08, 2020 Filed Jun 9, 2020 16:26 UTC |
BISHOP JOHN LDirector
|
GrantStock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $26.30 | $0.00 |
DisclosureSEC source: 0001384101-20-000085 · wf-form4_159173439149687.xml · derivative · entry 1 BISHOP JOHN L · CIK 0001189846 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2030-06-07 F1 · derivative.exercise_date: The option becomes exercisable in full on June 8, 2021 or immediately prior to the Company's next annual meeting of stockholders, if earlier. In addition, the option vests in full in the event of a change in control of the Company. Read SEC document |
| June 08, 2020 Filed Jun 9, 2020 20:49 UTC |
GORDON KEVIN KDirector
|
GrantStock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $26.30 | $0.00 |
DisclosureSEC source: 0001384101-20-000097 · wf-form4_159173575610370.xml · derivative · entry 1 GORDON KEVIN K · CIK 0001218483 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2030-06-07 F1 · derivative.exercise_date: The option becomes exercisable in full on June 8, 2021 or immediately prior to the Company's next annual meeting of stockholders, if earlier. In addition, the option vests in full in the event of a change in control of the Company. Read SEC document |
| June 08, 2020 Filed Jun 9, 2020 20:45 UTC |
Cohen Fred EDirector
|
GrantStock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $26.30 | $0.00 |
DisclosureSEC source: 0001384101-20-000093 · wf-form4_159173550019404.xml · derivative · entry 1 Cohen Fred E · CIK 0001339358 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2030-06-07 F1 · derivative.exercise_date: The option becomes exercisable in full on June 8, 2021 or immediately prior to the Company's next annual meeting of stockholders, if earlier. In addition, the option vests in full in the event of a change in control of the Company. Read SEC document |
| June 03, 2020 Filed Jun 4, 2020 20:16 UTC |
Kennedy Giulia CChief Scientific & Med Officer
|
Exercise / conversionStock Option (right to buy) · Derivative | 5,312 | $0.00 Strike: $9.05 | $0.00 |
DisclosureSEC source: 0001384101-20-000080 · wf-form4_159130180118115.xml · derivative · entry 8 Kennedy Giulia C · CIK 0001769333 · Chief Scientific & Med Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,938 Underlying: Common Stock · 5,312 shares Expires 2027-03-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on May 3, 2019. F6 · derivative.exercise_date: The option becomes exercisable as to 25% of the shares on March 2, 2019, and the remaining shares vest at a rate of 1/48th of the total number of shares subject to the award for each month of continuous service thereafter. Read SEC document |
| June 03, 2020 Filed Jun 4, 2020 20:16 UTC |
Kennedy Giulia CChief Scientific & Med Officer
|
Exercise / conversionStock Option (right to buy) · Derivative | 4,406 | $0.00 Strike: $5.98 | $0.00 |
DisclosureSEC source: 0001384101-20-000080 · wf-form4_159130180118115.xml · derivative · entry 7 Kennedy Giulia C · CIK 0001769333 · Chief Scientific & Med Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,844 Underlying: Common Stock · 4,406 shares Expires 2028-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on May 3, 2019. F5 · derivative.exercise_date: The option becomes exercisable as to 25% of the shares on March 3, 2018, and the remaining shares vest at a rate of 1/48th of the total number of shares subject to the award for each month of continuous service thereafter. Read SEC document |
| June 03, 2020 Filed Jun 4, 2020 20:16 UTC |
Kennedy Giulia CChief Scientific & Med Officer
|
Exercise / conversionStock Option (right to buy) · Derivative | 521 | $0.00 Strike: $5.43 | $0.00 |
DisclosureSEC source: 0001384101-20-000080 · wf-form4_159130180118115.xml · derivative · entry 6 Kennedy Giulia C · CIK 0001769333 · Chief Scientific & Med Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1 Underlying: Common Stock · 521 shares Expires 2026-03-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on May 3, 2019. F4 · derivative.exercise_date: The option becomes exercisable as to 25% of the shares on March 15, 2017, and the remaining shares vest at a rate of 1/48th of the total number of shares subject to the award for each month of continuous service thereafter. Read SEC document |
| June 03, 2020 Filed Jun 4, 2020 20:16 UTC |
Kennedy Giulia CChief Scientific & Med Officer
|
SaleCommon Stock | 10,786 | $26.22 | $282,808.92 |
DisclosureSEC source: 0001384101-20-000080 · wf-form4_159130180118115.xml · nonDerivative · entry 5 Kennedy Giulia C · CIK 0001769333 · Chief Scientific & Med Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,487 F2 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on May 3, 2019. F3 · price: Represents weighted average sales price. Sale prices for the transactions range from $25.84 to $26.62. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request. Read SEC document |
| June 03, 2020 Filed Jun 4, 2020 20:16 UTC |
Kennedy Giulia CChief Scientific & Med Officer
|
Exercise / conversionCommon Stock | 5,312 | $9.05 | $48,073.60 |
DisclosureSEC source: 0001384101-20-000080 · wf-form4_159130180118115.xml · nonDerivative · entry 4 Kennedy Giulia C · CIK 0001769333 · Chief Scientific & Med Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 91,273 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on May 3, 2019. Read SEC document |
| June 03, 2020 Filed Jun 4, 2020 20:16 UTC |
Kennedy Giulia CChief Scientific & Med Officer
|
Exercise / conversionCommon Stock | 4,406 | $5.98 | $26,347.88 |
DisclosureSEC source: 0001384101-20-000080 · wf-form4_159130180118115.xml · nonDerivative · entry 3 Kennedy Giulia C · CIK 0001769333 · Chief Scientific & Med Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,961 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on May 3, 2019. Read SEC document |
| June 03, 2020 Filed Jun 4, 2020 20:16 UTC |
Kennedy Giulia CChief Scientific & Med Officer
|
Exercise / conversionCommon Stock | 521 | $5.43 | $2,829.03 |
DisclosureSEC source: 0001384101-20-000080 · wf-form4_159130180118115.xml · nonDerivative · entry 2 Kennedy Giulia C · CIK 0001769333 · Chief Scientific & Med Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,555 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on May 3, 2019. Read SEC document |
| June 02, 2020 Filed Jun 4, 2020 20:16 UTC |
Kennedy Giulia CChief Scientific & Med Officer
|
Tax withholdingCommon Stock | 540 | $26.01 | $14,045.40 |
DisclosureSEC source: 0001384101-20-000080 · wf-form4_159130180118115.xml · nonDerivative · entry 1 Kennedy Giulia C · CIK 0001769333 · Chief Scientific & Med Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,034 F1 · kind: The reporting person is reporting the withholding of 292 and 248 shares of common stock to satisfy the reporting person's tax withholding obligations in connection with the vesting of 587 and 500 Restricted Stock Units, respectively, granted on March 2, 2018 and February 28, 2019, respectively, and does not represent a sale by the reporting person. Read SEC document |
| June 02, 2020 Filed Jun 4, 2020 20:15 UTC |
Kennedy KeithCOO / CFO
|
Tax withholdingCommon Stock | 603 | $26.01 | $15,684.03 |
DisclosureSEC source: 0001384101-20-000078 · wf-form4_159130169726252.xml · nonDerivative · entry 1 Kennedy Keith · CIK 0001543503 · COO / CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 157,704 F1 · kind: The reporting person is reporting the withholding of 339 and 264 shares of common stock to satisfy the reporting person's tax withholding obligations in connection with the vesting of 643 and 500 Restricted Stock Units, respectively granted on March 2, 2018 and February 28, 2019, respectively, and does not represent a sale by the reporting person. Read SEC document |
| June 02, 2020 Filed Jun 4, 2020 20:12 UTC |
Ho MarkPrincipal Accounting Officer
|
Tax withholdingCommon Stock | 152 | $26.01 | $3,953.52 |
DisclosureSEC source: 0001384101-20-000076 · wf-form4_159130152905262.xml · nonDerivative · entry 1 Ho Mark · CIK 0001554165 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,472 F1 · kind: The reporting person is reporting the withholding of 65 and 87 shares of common stock to satisfy the reporting person's tax withholding obligations in connection with the vesting of 187 and 250 Restricted Stock Units, respectively, granted on March 2, 2018 and February 28, 2019, respectively, and does not represent a sale by the reporting person. Read SEC document |
| June 02, 2020 Filed Jun 4, 2020 20:09 UTC |
Anderson Bonnie HDirector · Chairman and CEO
|
Tax withholdingCommon Stock | 1,976 | $26.01 | $51,395.76 |
DisclosureSEC source: 0001384101-20-000074 · wf-form4_159130133957126.xml · nonDerivative · entry 1 Anderson Bonnie H · CIK 0001588970 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 272,207 F1 · kind: The reporting person is reporting the withholding of 988 and 988 shares of common stock to satisfy the reporting person's tax withholding obligations in connection with the vesting of 1,875 and 1,875 Restricted Stock Units, respectively granted on March 2, 2018 and February 28, 2019, respectively, and does not represent a sale by the reporting person. Read SEC document |
| June 02, 2020 Filed Jun 4, 2020 20:07 UTC |
Hanna John Walter JRChief Commercial Officer
|
Tax withholdingCommon Stock | 325 | $26.01 | $8,453.25 |
DisclosureSEC source: 0001384101-20-000072 · wf-form4_159130122706539.xml · nonDerivative · entry 1 Hanna John Walter JR · CIK 0001781127 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,524 F1 · kind: The reporting person is reporting the withholding of 152 and 173 shares of common stock to satisfy the reporting person's tax withholding obligations in connection with the vesting of 437 and 500 Restricted Stock Units, respectively, granted on March 2, 2018 and February 28, 2019, respectively and does not represent a sale by the reporting person. Read SEC document |
| May 18, 2020 Filed May 19, 2020 20:04 UTC |
Cohen Fred EDirector
|
SaleCommon Stock | 4,153 | $27.51 | $114,235.74 |
DisclosureSEC source: 0001384101-20-000070 · wf-form4_158991866706680.xml · nonDerivative · entry 2 Cohen Fred E · CIK 0001339358 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F2 · price: Represents weighted average sales price. Sale prices for the transactions range from $27.47 to $27.60. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request. Read SEC document |
| May 18, 2020 Filed May 19, 2020 20:04 UTC |
Cohen Fred EDirector
|
SaleCommon Stock | 35,847 | $26.79 | $960,319.62 |
DisclosureSEC source: 0001384101-20-000070 · wf-form4_158991866706680.xml · nonDerivative · entry 1 Cohen Fred E · CIK 0001339358 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,153 F1 · price: Represents weighted average sales price. Sale prices for the transactions range from $26.41 to $27.36. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request. Read SEC document |
| May 11, 2020 Filed May 13, 2020 20:54 UTC |
Kennedy Giulia CChief Scientific & Med Officer
|
GrantStock Option (right to buy) · Derivative | 1,750 | $0.00 Strike: $26.55 | $0.00 |
DisclosureSEC source: 0001384101-20-000066 · wf-form4_158940324697521.xml · derivative · entry 2 Kennedy Giulia C · CIK 0001769333 · Chief Scientific & Med Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,750 Underlying: Common Stock · 1,750 shares Expires 2030-05-10 F2 · derivative.exercise_date: The stock options awarded on May 11, 2020 vest 18 months from May 1, 2020 subject to continuing employment of the Reporting Person on the vesting date. Read SEC document |
| May 11, 2020 Filed May 13, 2020 20:54 UTC |
Kennedy Giulia CChief Scientific & Med Officer
|
GrantCommon Stock | 300 | $0.00 | $0.00 |
DisclosureSEC source: 0001384101-20-000066 · wf-form4_158940324697521.xml · nonDerivative · entry 1 Kennedy Giulia C · CIK 0001769333 · Chief Scientific & Med Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,574 F1 · kind: Restricted stock units awarded on May 11, 2020 vest 18 months from May 1, 2020 subject to continuing employment of the Reporting Person on the vesting date. Read SEC document |
| May 11, 2020 Filed May 13, 2020 20:56 UTC |
Ho MarkPrincipal Accounting Officer
|
GrantStock Option (right to buy) · Derivative | 1,190 | $0.00 Strike: $26.55 | $0.00 |
DisclosureSEC source: 0001384101-20-000068 · wf-form4_158940335032897.xml · derivative · entry 2 Ho Mark · CIK 0001554165 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,190 Underlying: Common Stock · 1,190 shares Expires 2030-05-10 F2 · derivative.exercise_date: The stock options awarded on May 11, 2020 vest 18 months from May 1, 2020 subject to continuing employment of the Reporting Person on the vesting date. Read SEC document |
| May 11, 2020 Filed May 13, 2020 20:56 UTC |
Ho MarkPrincipal Accounting Officer
|
GrantCommon Stock | 205 | $0.00 | $0.00 |
DisclosureSEC source: 0001384101-20-000068 · wf-form4_158940335032897.xml · nonDerivative · entry 1 Ho Mark · CIK 0001554165 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,624 F1 · kind: Restricted stock units awarded on May 11, 2020 vest 18 months from May 1, 2020 subject to continuing employment of the Reporting Person on the vesting date. Read SEC document |
| May 11, 2020 Filed May 13, 2020 20:53 UTC |
Kennedy KeithCOO / CFO
|
GrantStock Option (right to buy) · Derivative | 1,750 | $0.00 Strike: $26.55 | $0.00 |
DisclosureSEC source: 0001384101-20-000065 · wf-form4_158940318286618.xml · derivative · entry 2 Kennedy Keith · CIK 0001543503 · COO / CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,750 Underlying: Common Stock · 1,750 shares Expires 2030-05-10 F2 · derivative.exercise_date: The stock options awarded on May 11, 2020 vest 18 months from May 1, 2020 subject to continuing employment of the Reporting Person on the vesting date. Read SEC document |
| May 11, 2020 Filed May 13, 2020 20:53 UTC |
Kennedy KeithCOO / CFO
|
GrantCommon Stock | 300 | $0.00 | $0.00 |
DisclosureSEC source: 0001384101-20-000065 · wf-form4_158940318286618.xml · nonDerivative · entry 1 Kennedy Keith · CIK 0001543503 · COO / CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 158,307 F1 · kind: Restricted stock units awarded on May 11, 2020 vest 18 months from May 1, 2020 subject to continuing employment of the Reporting Person on the vesting date. Read SEC document |
| May 11, 2020 Filed May 13, 2020 20:52 UTC |
Hanna John Walter JRChief Commercial Officer
|
GrantStock Option (right to buy) · Derivative | 1,540 | $0.00 Strike: $26.55 | $0.00 |
DisclosureSEC source: 0001384101-20-000064 · wf-form4_158940312296863.xml · derivative · entry 2 Hanna John Walter JR · CIK 0001781127 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,540 Underlying: Common Stock · 1,540 shares Expires 2030-05-10 F2 · derivative.exercise_date: The stock options awarded on May 11, 2020 vest 18 months from May 1, 2020 subject to continuing employment of the Reporting Person on the vesting date Read SEC document |
| May 11, 2020 Filed May 13, 2020 20:52 UTC |
Hanna John Walter JRChief Commercial Officer
|
GrantCommon Stock | 265 | $0.00 | $0.00 |
DisclosureSEC source: 0001384101-20-000064 · wf-form4_158940312296863.xml · nonDerivative · entry 1 Hanna John Walter JR · CIK 0001781127 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,849 F1 · kind: Restricted stock units awarded on May 11, 2020 vest 18 months from May 1, 2020 subject to continuing employment of the Reporting Person on the vesting date. Read SEC document |
| May 11, 2020 Filed May 13, 2020 20:47 UTC |
Anderson Bonnie HDirector · Chairman and CEO
|
Exercise / conversionStock Option (right to buy) · Derivative | 20,000 | $4.00 Strike: $4.00 | $80,000.00 |
DisclosureSEC source: 0001384101-20-000060 · wf-form4_158940284059359.xml · derivative · entry 7 Anderson Bonnie H · CIK 0001588970 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,853 Underlying: Common Stock · 20,000 shares Expires 2023-02-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · shares: On February 5, 2013, the Reporting Person was issued 3 stock options which have different vesting dates, all of which are vested. These options include: (1) 112,500, of which 5,241 shares are exercised on 5/11/2020 and 25,000 options remain, (2) 12,500, of which 12,500 are exercised on 5/11/2020 and none remain and (3) 24,112, of which 2,259 were exercised on 5/11/2020 and 21,853 remain. F6 · derivative.exercise_date: The options are fully vested. Read SEC document |
| May 11, 2020 Filed May 13, 2020 20:47 UTC |
Anderson Bonnie HDirector · Chairman and CEO
|
GrantStock Option (right to buy) · Derivative | 10,920 | $0.00 Strike: $26.55 | $0.00 |
DisclosureSEC source: 0001384101-20-000060 · wf-form4_158940284059359.xml · derivative · entry 6 Anderson Bonnie H · CIK 0001588970 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,920 Underlying: Common Stock · 10,920 shares Expires 2030-05-10 F4 · derivative.exercise_date: The stock options awarded on May 11, 2020 vest 24 months from May 1, 2020 subject to continuing employment of the Reporting Person on the vesting date. Read SEC document |
| May 11, 2020 Filed May 13, 2020 20:47 UTC |
Anderson Bonnie HDirector · Chairman and CEO
|
SaleCommon Stock | 200 | $27.10 | $5,420.00 |
DisclosureSEC source: 0001384101-20-000060 · wf-form4_158940284059359.xml · nonDerivative · entry 4 Anderson Bonnie H · CIK 0001588970 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 274,183 F2 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 2, 2019. Read SEC document |
| May 11, 2020 Filed May 13, 2020 20:47 UTC |
Anderson Bonnie HDirector · Chairman and CEO
|
SaleCommon Stock | 19,800 | $26.66 | $527,913.54 |
DisclosureSEC source: 0001384101-20-000060 · wf-form4_158940284059359.xml · nonDerivative · entry 3 Anderson Bonnie H · CIK 0001588970 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 274,383 F2 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 2, 2019. F3 · price: Represents weighted average sales price. Sale prices for the transactions range from $26.08 to $27.03. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request. Read SEC document |
| May 11, 2020 Filed May 13, 2020 20:47 UTC |
Anderson Bonnie HDirector · Chairman and CEO
|
Exercise / conversionCommon Stock | 20,000 | $4.00 | $80,000.00 |
DisclosureSEC source: 0001384101-20-000060 · wf-form4_158940284059359.xml · nonDerivative · entry 2 Anderson Bonnie H · CIK 0001588970 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 294,183 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 2, 2019. Read SEC document |
| May 11, 2020 Filed May 13, 2020 20:47 UTC |
Anderson Bonnie HDirector · Chairman and CEO
|
GrantCommon Stock | 1,870 | $0.00 | $0.00 |
DisclosureSEC source: 0001384101-20-000060 · wf-form4_158940284059359.xml · nonDerivative · entry 1 Anderson Bonnie H · CIK 0001588970 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 274,183 F1 · kind: Restricted stock units awarded on May 11, 2020 vest 24 months from May 1, 2020 subject to continuing employment of the Reporting Person on the vesting date. Read SEC document |
| March 20, 2020 Filed Mar 23, 2020 21:01 UTC |
Anderson Bonnie HDirector · Chairman and CEO
|
Exercise / conversionStock Option (right to buy) · Derivative | 16,000 | $0.00 Strike: $2.68 | $0.00 |
DisclosureSEC source: 0001384101-20-000043 · wf-form4_158499725312617.xml · derivative · entry 3 Anderson Bonnie H · CIK 0001588970 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,313 Underlying: Common Stock · 16,000 shares Expires 2022-03-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The option is fully vested. Read SEC document |
| March 20, 2020 Filed Mar 23, 2020 21:01 UTC |
Anderson Bonnie HDirector · Chairman and CEO
|
Exercise / conversionCommon Stock | 16,000 | $2.68 | $42,880.00 |
DisclosureSEC source: 0001384101-20-000043 · wf-form4_158499725312617.xml · nonDerivative · entry 1 Anderson Bonnie H · CIK 0001588970 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 272,313 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 10, 2020 Filed Mar 11, 2020 21:05 UTC |
Anderson Bonnie HDirector · Chairman and CEO
|
Exercise / conversionStock Option (right to buy) · Derivative | 20,000 | $0.00 Strike: $4.00 | $0.00 |
DisclosureSEC source: 0001384101-20-000041 · wf-form4_158396070314703.xml · derivative · entry 4 Anderson Bonnie H · CIK 0001588970 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,241 Underlying: Common Stock · 20,000 shares Expires 2023-02-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 2, 2019. F3 · derivative.exercise_date: The option is fully vested. Read SEC document |
| March 10, 2020 Filed Mar 11, 2020 21:05 UTC |
Anderson Bonnie HDirector · Chairman and CEO
|
SaleCommon Stock | 20,000 | $25.18 | $503,520.00 |
DisclosureSEC source: 0001384101-20-000041 · wf-form4_158396070314703.xml · nonDerivative · entry 2 Anderson Bonnie H · CIK 0001588970 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 256,313 F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 2, 2019. F2 · price: Represents weighted average sales price. Sale prices for the transactions range from $25.00 to $25.41. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request. Read SEC document |
| March 10, 2020 Filed Mar 11, 2020 21:05 UTC |
Anderson Bonnie HDirector · Chairman and CEO
|
Exercise / conversionCommon Stock | 20,000 | $4.00 | $80,000.00 |
DisclosureSEC source: 0001384101-20-000041 · wf-form4_158396070314703.xml · nonDerivative · entry 1 Anderson Bonnie H · CIK 0001588970 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 276,313 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 2, 2019. Read SEC document |
| March 03, 2020 Filed Mar 3, 2020 22:58 UTC |
Hanna John Walter JRChief Commercial Officer
|
Tax withholdingCommon Stock | 2,888 | $0.00 | $0.00 |
DisclosureSEC source: 0001384101-20-000035 · wf-form4_158327630587282.xml · nonDerivative · entry 3 Hanna John Walter JR · CIK 0001781127 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,584 F3 · kind: Shares relinquished by the Reporting Person and cancelled by the Issuer in exchange for the Issuer's agreement to pay federal and state tax withholding obligations of the Reporting Person resulting from the vesting of restricted stock units. The Reporting Person did not sell or otherwise dispose of the shares for any reason other than to cover required taxes. Read SEC document |
| March 03, 2020 Filed Mar 4, 2020 22:49 UTC |
Kennedy Giulia CChief Scientific & Med Officer
|
Exercise / conversionStock Option (right to buy) · Derivative | 4,407 | $5.98 Strike: $5.98 | $26,353.86 |
DisclosureSEC source: 0001384101-20-000039 · wf-form4_158336213084937.xml · derivative · entry 10 Kennedy Giulia C · CIK 0001769333 · Chief Scientific & Med Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,250 Underlying: Common Stock · 4,407 shares Expires 2028-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on May 3, 2019. F7 · derivative.exercise_date: The option became exercisable as to 25% of the shares on March 2, 2019, and the remaining shares vest at a rate of 1/48th of the total number of shares subject to the award for each month of continuous service thereafter. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.